{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:01:58Z","timestamp":1785888118928,"version":"3.56.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00210-024-03570-1","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T11:17:28Z","timestamp":1730287048000},"page":"4409-4417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of ophthalmic preparation of methyldopa on induced ocular hypertension in rabbits"],"prefix":"10.1007","volume":"398","author":[{"given":"Fouad Kadhim","family":"Gatea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7011-5186","authenticated-orcid":false,"given":"Zeena Ayad","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitham Mahmood","family":"Kadhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Rahma","family":"Abu-Raghif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"3570_CR1","doi-asserted-by":"publisher","unstructured":"Abdulsahib WK, Abood SJ (2021) The effect of calcium channel blocker in the betamethasone-induced glaucoma model in rabbits. J Adv Pharm Educ Res, 11(1):135-40. https:\/\/doi.org\/10.51847\/2d3w8vfSVt","DOI":"10.51847\/2d3w8vfSVt"},{"issue":"1","key":"3570_CR2","first-page":"96","volume":"35","author":"WK Abdulsahib","year":"2015","unstructured":"Abdulsahib WK, Al-Zubaidy A, Sahib HB et al (2015) Tolerable ocular hypotensive effect of topically applied sildenafil in ocular in normotensive and betamethasone-induced hypertensive rabbits. Int J Pharm Sci Rev Res 35(1):96\u2013102","journal-title":"Int J Pharm Sci Rev Res"},{"key":"3570_CR3","unstructured":"Ahuja M (2003) Ophthalmology Handbook. 1st ed. India Binding House. Delhi., Pp. 6-24, 145-163"},{"key":"3570_CR4","first-page":"540","volume-title":"Ansel\u2019s pharmaceutical dosage forms and drug delivery systems","author":"LV Allen","year":"2005","unstructured":"Allen LV, Popovich NG, Ansel HC (2005) Ansel\u2019s pharmaceutical dosage forms and drug delivery systems, 8th edn. Lippincott Williams and Wilkins, Philadelphia, pp 540\u2013569","edition":"8"},{"issue":"1","key":"3570_CR5","first-page":"76","volume":"47","author":"AAK Alwany","year":"2017","unstructured":"Alwany AAK, Abu-Raghif AR, Rasheed AM (2017) Effect of bosentan on the intraocular pressure of normal and ocular-induced hypertensive rabbits. Int J Pharm Sci Rev Res 47(1):76\u201382","journal-title":"Int J Pharm Sci Rev Res"},{"key":"3570_CR6","doi-asserted-by":"publisher","unstructured":"Amato R (2022) In vivo murine models for the study of glaucoma pathophysiology: procedures, analyses, and typical outcomes. Ann Eye Sci 7:30. https:\/\/doi.org\/10.21037\/aes-21-48","DOI":"10.21037\/aes-21-48"},{"key":"3570_CR7","volume-title":"Terminology and guidelines for glaucoma","author":"A Azuara-Blanco","year":"2020","unstructured":"Azuara-Blanco A, Bgnasco L, Bagnis A et al (2020) Terminology and guidelines for glaucoma. European Glaucoma Society, Edinburgh, UK"},{"key":"3570_CR8","doi-asserted-by":"publisher","first-page":"942","DOI":"10.2174\/1570159X15666170720094529","volume":"16","author":"K Bell","year":"2018","unstructured":"Bell K, Und Hohenstein-Blaul NVT, Teister J et al (2018) Modulation of the immune system for the treatment of glaucoma. Curr Neuropharmacol 16:942\u2013958","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"3570_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-98762-7","volume":"11","author":"CJ Bertens","year":"2021","unstructured":"Bertens CJ, Van Mechelen RJ, Berendschot TT et al (2021) Repeatability, reproducibility, and agreement of three tonometers for measuring intraocular pressure in rabbits. Sci Rep 11(1):1\u201312. https:\/\/doi.org\/10.1038\/s41598-021-98762-7","journal-title":"Sci Rep"},{"issue":"5","key":"3570_CR10","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3390\/molecules26051259","volume":"26","author":"A Bogacz","year":"2021","unstructured":"Bogacz A, Miko\u0142ajczak P\u0141, Wolek M et al (2021) Combined effects of methyldopa and flavonoids on the expression of selected factors related to inflammatory processes and vascular diseases in human placenta cells\u2014an in vitro study. Molecules 26(5):1259. https:\/\/doi.org\/10.3390\/molecules26051259","journal-title":"Molecules"},{"key":"3570_CR11","unstructured":"Brian B, Hoffman BB (2007) Adrenoceptor activation and other sympathomimetic drugs. In: Katzung B.G. Basic and clinical pharmacology. 10th ed. McGraw Hill, Boston. 126, 137,138"},{"key":"3570_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0976-500x.119726","volume":"4","author":"J Charan","year":"2013","unstructured":"Charan J, Kantharia ND (2013) How to calculate sample size in animal studies? J Pharmacol Pharmacother 4:303\u2013306. https:\/\/doi.org\/10.4103\/0976-500x.119726","journal-title":"J Pharmacol Pharmacother"},{"key":"3570_CR13","first-page":"e140","volume":"102","author":"MF Cordeiro","year":"2023","unstructured":"Cordeiro MF, Gandolfi S, Gugleta K et al (2023) How latanoprost changed glaucoma management. Acta Ophthalmol. 102:e140\u2013e155","journal-title":"Acta Ophthalmol."},{"key":"3570_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1590\/S0004-27492012000100016","volume":"75","author":"FM Damico","year":"2012","unstructured":"Damico FM, Gasparin F, Scolari MR et al (2012) New approaches and potential treatments for dry age-related macular degeneration. Arq Bras Oftalmol 75:71\u201376. https:\/\/doi.org\/10.1590\/S0004-27492012000100016","journal-title":"Arq Bras Oftalmol"},{"issue":"6","key":"3570_CR15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/medicina55060280","volume":"55","author":"K Evangelho","year":"2019","unstructured":"Evangelho K, Mastronardi CA (2019) Experimental models of glaucoma: a powerful translational tool for the future development of new therapies for glaucoma in humans\u2014a review of the literature. Medicina 55(6):280. https:\/\/doi.org\/10.3390\/medicina55060280","journal-title":"Medicina"},{"key":"3570_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/bf03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang AG et al (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 39:175\u2013191. https:\/\/doi.org\/10.3758\/bf03193146","journal-title":"Behav Res Methods."},{"key":"3570_CR17","doi-asserted-by":"publisher","first-page":"117935","DOI":"10.1016\/j.lfs.2020.117935","volume":"256","author":"L Guan","year":"2020","unstructured":"Guan L, Li C, Zhang Y et al (2020) Puerarin ameliorates retinal ganglion cell damage induced by retinal ischemia\/reperfusion through inhibiting the activation of TLR4\/NLRP3 inflammasome. Life Sci 256:117935","journal-title":"Life Sci"},{"issue":"10","key":"3570_CR18","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1358\/mf.2007.29.10.1147765","volume":"29","author":"SK Gupta","year":"2007","unstructured":"Gupta SK, Agarwal R, Galpalli ND et al (2007) Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma. Methods Find Exp Clin Pharmacol 29(10):665\u201371","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"1","key":"3570_CR19","first-page":"579","volume":"12","author":"AH Hameed","year":"2020","unstructured":"Hameed AH, Kadhim HM, Rasheed AM (2020) The effects of topical adenosine agonists (Limonene) on induced ocular hypertension in rabbits. J Global Pharm Technol 12(1):579\u2013588","journal-title":"J Global Pharm Technol"},{"key":"3570_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2147\/OPTH.S442749","volume":"18","author":"DH Harvey","year":"2024","unstructured":"Harvey DH, Sugali CK, Mao W (2024) Glucocorticoid-induced ocular hypertension and glaucoma. Clin Ophthalmol 18:481\u2013505. https:\/\/doi.org\/10.2147\/OPTH.S442749","journal-title":"Clin Ophthalmol"},{"issue":"10","key":"3570_CR21","first-page":"1656","volume":"6","author":"MQ Hussein","year":"2017","unstructured":"Hussein MQ, Kadim HM, Abdulsahib WK (2017) Effect of telmisartan on intra-ocular pressure in induced open angle glaucoma in rabbits. Int J Sci Res (IJSR) 6(10):1656\u20131661","journal-title":"Int J Sci Res (IJSR)"},{"key":"3570_CR22","unstructured":"Jasim AH, Kadhim HM, Rasheed AM (2019a) Topical effects of atorvastatin on induced ocular hypertension in rabbits. Int J Biosci 14(2):272\u2013282"},{"key":"3570_CR23","unstructured":"Jasim AH, Kadim HM, Rasheed AM (2019b) Topical effects of metformin on induced ocular hypertension in rabbits. Indian J Nat Sci 9(52):16723\u201316734"},{"key":"3570_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.preteyeres.2014.11.004","volume":"45","author":"M Karlstetter","year":"2015","unstructured":"Karlstetter M, Scholz R, Rutar M et al (2015) Retinal microglia: just bystander or target for therapy? Prog Retin Eye Res 45:30\u201357","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"3570_CR25","first-page":"66","volume":"11","author":"E Khaled Alsirhani","year":"2020","unstructured":"Khaled Alsirhani E, Abdulaziz Ali YS, Mutlaq Ayidh Alosaimi S et al (2020) An overview of glaucoma diagnosis & management: a literature review. Arch Pharma Pract 11(4):66\u20139","journal-title":"Arch Pharma Pract"},{"key":"3570_CR26","first-page":"115","volume":"12","author":"SU Khan","year":"2014","unstructured":"Khan SU, Ashraf M, Salam A et al (2014) Steroid-induced ocular hypertension: an animal model. Gomal J Med Sci 12:115\u20137","journal-title":"Gomal J Med Sci"},{"issue":"3","key":"3570_CR27","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3390\/molecules27030707","volume":"27","author":"L-Y Lee","year":"2022","unstructured":"Lee L-Y, Hsu J-H, Fu H-I et al (2022) Lowering the intraocular pressure in rats and rabbits by Cordyceps cicadae extract and its active compounds. Molecules. 27(3):707. https:\/\/doi.org\/10.3390\/molecules27030707","journal-title":"Molecules."},{"key":"3570_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/archopht.121.1.48","volume":"121","author":"MC Leske","year":"2003","unstructured":"Leske MC, Heijl A, Hussein M et al (2003) Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 121:48\u201356","journal-title":"Arch Ophthalmol"},{"key":"3570_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/ceo.14043","volume":"50","author":"DYL Leung","year":"2022","unstructured":"Leung DYL, Tham CC (2022) Normal-tension glaucoma: current concepts and approaches-a review. Clin Exp Ophthalmol 50:247\u2013259","journal-title":"Clin Exp Ophthalmol"},{"issue":"9","key":"3570_CR30","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.ophtha.2012.02.050","volume":"119","author":"SL Mansberger","year":"2012","unstructured":"Mansberger SL, Gordon MO, Jampel H et al (2012) Reduction in intraocular pressure after cataract extraction: the ocular hypertension treatment study. Ophthalmology 119(9):1826. https:\/\/doi.org\/10.1016\/j.ophtha.2012.02.050","journal-title":"Ophthalmology"},{"issue":"1","key":"3570_CR31","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S0022-3565(24)37192-7","volume":"284","author":"J Melena","year":"1998","unstructured":"Melena J, Santaf\u00e9 J, Segarra J (1998) The effect of topical diltiazem on the intraocular pressure in betamethasone-induced ocular hypertensive rabbits. J Pharmacol Exp Ther 284(1):278\u2013282","journal-title":"J Pharmacol Exp Ther"},{"key":"3570_CR32","doi-asserted-by":"publisher","first-page":"103186","DOI":"10.1016\/j.redox.2024.103186","volume":"73","author":"R Mori","year":"2024","unstructured":"Mori R, Abe M, Saimoto Y et al (2024) Construction of a screening system for lipid-derived radical inhibitors and validation of hit compounds to target retinal and cerebrovascular diseases. Redox Biol 73:103186. https:\/\/doi.org\/10.1016\/j.redox.2024.103186","journal-title":"Redox Biol"},{"key":"3570_CR33","doi-asserted-by":"publisher","first-page":"S1923","DOI":"10.1016\/j.arabjc.2013.07.021","volume":"10","author":"M Noei","year":"2017","unstructured":"Noei M, Holoosadi M, Anaraki-Ardakani H (2017) Design of methyldopa structure and calculation of its properties by quantum mechanics. Arab J Chem 10:S1923\u2013S1937. https:\/\/doi.org\/10.1016\/j.arabjc.2013.07.021","journal-title":"Arab J Chem"},{"key":"3570_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaapos.2016.09.026","volume":"21","author":"B Nuyen","year":"2017","unstructured":"Nuyen B, Weinreb RN, Robbins SL (2017) Steroid-induced glaucoma in the pediatric population. J Am Assoc Pediatr Ophthalmol Strabismus 21:1\u20136","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"3570_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.exer.2015.06.002","volume":"141","author":"DR Overby","year":"2015","unstructured":"Overby DR, Clark AF (2015) Animal models of glucocorticoid-induced glaucoma. Exp Eye Res 141:15\u201322","journal-title":"Exp Eye Res"},{"issue":"7","key":"3570_CR36","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Ahluwalia A, Alam S et al (2020) Reporting animal research: explanation and elaboration for the ARRIVE guidelines 20. PLoS Biol 18(7):e3000411. https:\/\/doi.org\/10.1371\/journal.pbio.3000411","journal-title":"PLoS Biol"},{"key":"3570_CR37","unstructured":"Peter NB, Brown MJ, Pankaj S (2012) Clinical pharmacology; Churchill Livingstone, 11th edition, 995"},{"issue":"8","key":"3570_CR38","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1001\/archopht.1984.01040030958024","volume":"102","author":"G Petursson","year":"1984","unstructured":"Petursson G, Cole R, Hanna C (1984) Treatment of glaucoma using minidrops of clonidine. Arch Ophthalmol 102(8):1180\u20131181. https:\/\/doi.org\/10.1001\/archopht.1984.01040030958024","journal-title":"Arch Ophthalmol"},{"key":"3570_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5005\/jp-journals-10028-1226","volume":"11","author":"S Phulke","year":"2017","unstructured":"Phulke S, Kaushik S, Kaur S et al (2017) Steroid-induced glaucoma: an avoidable irreversible blindness. J Curr Glaucoma Pract 11:67\u201372","journal-title":"J Curr Glaucoma Pract"},{"key":"3570_CR40","unstructured":"Prunte C, Markstein R (2000) Adrenergic regulation and its therapeutic aspects in the eye In: Orgul S., Flammer J. Pharmaco -therapy in Glaucoma, pp 73-78"},{"key":"3570_CR41","doi-asserted-by":"publisher","unstructured":"Puris E, Gynther M, Auriola S et al. (2020) L-Type amino acid transporter 1 as a target for drug delivery, Pharm. Res., (N. Y.) 37 https:\/\/doi.org\/10.1007\/S11095-020-02826-8","DOI":"10.1007\/S11095-020-02826-8"},{"key":"3570_CR42","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1136\/bjo.2004.052860","volume":"89","author":"M Seki","year":"2005","unstructured":"Seki M, Tanaka T, Matsuda H et al (2005) Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model. Br J Ophthalmol 89:504\u2013507","journal-title":"Br J Ophthalmol"},{"key":"3570_CR43","first-page":"160","volume":"75","author":"A Seremak-Mrozikiewicz","year":"2004","unstructured":"Seremak-Mrozikiewicz A, Drews K (2004) Methyldopa in therapy of hypertension in pregnant women. Ginekol. Pol. 75:160\u2013165","journal-title":"Ginekol. Pol."},{"issue":"6","key":"3570_CR44","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/ijms25063328","volume":"25","author":"NA Sharif","year":"2024","unstructured":"Sharif NA, Millar JC, Zode G et al (2024) Steroid-induced ocular hypertension in mice is differentially reduced by selective EP2, EP3, EP4, and IP prostanoid receptor agonists. Int J Mol Scis 25(6):3328. https:\/\/doi.org\/10.3390\/ijms25063328","journal-title":"Int J Mol Scis"},{"key":"3570_CR45","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/metabo13020187","volume":"13","author":"DY Shu","year":"2023","unstructured":"Shu DY, Chaudhary S, Cho KS et al (2023) Role of oxidative stress in ocular diseases: a balancing act. Metabolites 13:187","journal-title":"Metabolites"},{"issue":"1","key":"3570_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-053805","volume":"12","author":"Y Sun","year":"2022","unstructured":"Sun Y, Chen A, Zou M et al (2022) Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017. BMJ Open 12(1):e053805. https:\/\/doi.org\/10.1136\/bmjopen-2021-053805","journal-title":"BMJ Open"},{"key":"3570_CR47","first-page":"563","volume":"17","author":"A Trivli","year":"2019","unstructured":"Trivli A, Koliarakis I, Terzidou C et al (2019) Normaltension glaucoma: pathogenesis and genetics. Exp Ther Med 17:563\u2013574","journal-title":"Exp Ther Med"},{"key":"3570_CR48","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3390\/ijms25020906","volume":"25","author":"T Tsai","year":"2024","unstructured":"Tsai T, Reinehr S, Deppe L et al (2024) Glaucoma animal models beyond chronic IOP increase. Int J Mol Sci 25:906. https:\/\/doi.org\/10.3390\/ijms25020906","journal-title":"Int J Mol Sci"},{"key":"3570_CR49","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1463-5224.2006.00495.x","volume":"9","author":"L Werner","year":"2006","unstructured":"Werner L, Chew J, Mamalis N (2006) Experimental evaluation of ophthalmic devices and solutions using rabbit models. Vet Ophthalmol 9:281\u2013291","journal-title":"Vet Ophthalmol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03570-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03570-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03570-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:02:17Z","timestamp":1744149737000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03570-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3570"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03570-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5234809\/v1","asserted-by":"object"}]},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study\u2019s experimental requirements and procedures follow the National Center of the 3Rs (NC3Rs) and the ARRIVE 2.0 guidelines (Percie du Sert et al.\n                      \n                      ). An ethical statement was granted by the Institute Review Board (IRB) of the College of Medicine\/Al-Nahrain University (issue no.: 20240901; Date: 8\/10\/2024)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}